| Welcom/Opeing Remarks: |
| Carola Schropp, MBA, MTS - President & Founder, EBD Group |
| Greg B. Scott - President & Founder, ChinaBio· LLC |
| Barry Yang - Chairman, Suzhou Industrial Park |
| Yuwen Liu, MBA - Chairwoman & CEO, BioBay |
| Keynote Panel: Partnering Landscape in China-Keeping Pace with Change |
| David Chen, MD, MBA - Executive Vice President & COO, 3SBio Inc. |
| Edward Hu, MBA - COO, WuXi AppTec |
| Kewen Jin, PhD - General Manager, Charles River Greater China |
| Xin Ma, PhD - Head of Global Drug Discovery-Innovation Center China, Bayer Schering Pharma |
| Greg Wiederrecht, PhD, CLP - VP & Head, External Scientific Affairs, Worldwide Licensing, Merck Research Laboratories |
| Speakers: |
| Brian Cunningham, JD - Senior Counsel and Co-chair of Life Science Group,Morrison & Foerster LLP |
| Jie Liu D'Elia, PhD, MBA - VP, International Business Development, Simcere Pharma |
| Alex Fowkes, JD - Executive Director, Head of R&D Business Development, Pfizer Inc. |
| Michael Heerde, PhD, MBA - Director, Strategy and Business Development, Bayer Healthcare China |
| Ruediger Herrmann, PhD - Partner, WilmerHale |
| Avery Ince, MD, PhD - Medical Director, MSD China |
| Shawn Shiqing Li, JD, PhD - Associate, Blank Rome, LLP |
| Esther H. Lim, JD - Founding Managing Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Shanghai Office |
| Martina Molsbergen - CEO, C14 Consulting Group, LLC |
| John V. Oyler, MBA - former CEO, BioDuro, Inc. |
| Rajesh Parekh, PhD - Director, Head of Asia Healthcare Practice, McKinsey & Company |
| Eric Pierce - Publisher, BioCentury |
| J. Robert (Bob) Powell, PharmD - Scientific Advisor, Roche (China) Holding Ltd. |
| Jianzhong (David) Shen, JD, PhD - Asia Regional IP Counsel, Eli Lilly |
| Maria Song, PhD, MD - President, VPS-CRO Group |
| Howard Sui, PhD, MBA - Managing Director, Merck Serono China |
| Julian Thurston - Partner and Co-chair of Life Sciences Department, Morrison & Foerster LLP, UK |
| Breaux Walker - Managing Director, JMP Securities LLC |
| Jonathan Wang, PhD, MBA - Senior Managing Director, OrbiMed Asia |
| Ningling Wang, JD - Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Shanghai Office |
| Richard Wang, PhD, MBA - Director, Strategic Alliance and Collaboration, AstraZeneca |
| Xiaochuan Wang, PhD - Chairman & CEO, Sundia MediTech Co., Ltd. |
| Huacheng Wei, PhD - President, Beijing Pharmaceutical Group Co., Ltd. |
| Jimmy Wei, PhD, MBA - Senior Vice President, Business Development and Corporate Planning, Hutchison MediPhama Limited |
| Ian Wisenberg - Senior Vice President, Strategic Development, ChinaBio· LLC |
| Xiaobing Wu, PhD - General Manager, Pfizer China |
| Dajun Yang, MD, PhD - Co-Founder, President & CEO, Ascentage Pharma |
| Yanning Yi, MBA - Executive Director, The Balloch Group |
| Alfred W. Zaher, JD - Partner, Blank Rome LLP |
| Dan Zhang, MD, MPH - Chairman & CEO, Fountain Medical Development Ltd. |
| Ian Zhang - Head of Corporate Development, Asia Pacific, Life Technologies |
| Tony Zhang, PhD - Managing Director & Site Head, Lilly Global R&D, China |
| Larry Zhu, PhD, MBA - Director, External Scientific Affairs & Business Development, Janssen Pharmaceutical R&D, Asia Pacific |
Preliminary List of Participating Companies： |
| 0-9 |
| 3D BioOptima Co. Ltd. China |
| 3SBio Inc. China |
| A |
| A2 Bioscience Singapore |
| Abbott China |
| Abgent United States |
| Access Medical Systems United States |
| Acorn Campus China |
| Ajinomoto Pharmaceuticals Co., Ltd. Japan |
| Alexandria Real Estate Equities, Inc. United States |
| Alexza Pharmaceuticals, Inc. United States |
| Analis s.a. Belgium |
| AnaptysBio, Inc. United States |
| Argusina (Shanghai) Ltd. China |
| Ascentage Pharma China |
| Ascepion Pharmaceuticals China |
| AstraZeneca United Kingdom |
| AstraZeneca Pharmaceutical Company China |
| aTyr Pharma Inc China |
| AusBiotech Ltd Australia |
| Australian Trade Commission Australia |
| AWEX Belgium |
| B |
| Bachem AG Switzerland |
| Baxter Healthcare China |
| Bayer Schering Pharma AG Germany |
| Benitec Ltd Australia |
| BIA Separations GmesBH Austria |
| BioAtla LLC United States |
| BioBay China |
| BioCentury United States |
| BioFocus United Kingdom |
| Biotech Finances France |
| Blank Rome LLP United States |
| Bone Therapeutics Belgium |
| braymed China |
| Britannia Pharmaceuticals United Kingdom |
| Burnet Institute Australia |
| C |
| C14 Consulting Group, LLC United States |
| Cardiatis Belgium |
| Catalysis Argentina SA Argentina |
| Certech Belgium |
| Cevec Pharmaceuticals GmbH Germany |
| ChemPartner Denmark |
| ChinaBio? LLC China |
| Chiome Biosciences Inc. Japan |
| Chiral Quest (Suzhou) Co., Ltd. China |
| College of Pharmacy, Yantai University China |
| Copenhagen Capacity Denmark |
| Coris BioConcept Belgium |
| CPR Pharma Services Pty Ltd Australia |
| CrystalGenomics, Inc. South Korea |
| CSL Biotherapies Asia Pacific Ltd Hong Kong |
| Cyagen Biosciences China |
| D |
| Daiichi Sankyo Group United States |
| DANSK BIOTEK Denmark |
| Davies Collison Cave Australia |
| Delphi Genetics Belgium |
| Department of Innovation, Industry, Science and Research Australia |
| DesignMedix Inc United States |
| DNAVision Belgium |
| Dong-A Pharmaceutical South Korea |
| E |
| Easton Associates United States |
| EBD Group Germany |
| Eddingpharm China |
| Efficient Pharma Management Corporate Taiwan |
| Eli Lilly Trading (Shanghai) Co., Ltd China |
| ERA Consulting Australia |
| Ethypharm China |
| EUROFINS ADME BIOANALYSES France |
| EyeGene, Inc. South Korea |
| F |
| FABpharma France |
| Fujian Medical University China |
| FusoGen Pharmaceuticals, Inc. China |
| G |
| Genediag. Biotech, Kusan China |
| Gilead Sciences, Inc. United States |
| H |
| Hamilton Desanctis and Cha LLP United States |
| Hanmi Pharm. South Korea |
| healthcare angel United States |
| HUYA Bioscience China |
| I |
| IDEX Health & Science LLC United States |
| IDT Australia Limited Australia |
| Innovation China UK United Kingdom |
| International Project & Business Management Belgium |
| Invida Group Pte Ltd Singapore |
| Invida Group Pte Ltd Singapore |
| Ironwood Pharmaceuticals United States |
| it4ip Belgium |
| J |
| Japan Tobacco Pharma United States |
| Jijun Zhou China |
| K |
| Kibow Biotech Inc United States |
| Kinesis Pharma B.V. Netherlands |
| L |
| LAXAI United States |
| London Genetics United Kingdom |
| LTS Lohmann Therapie-Systeme AG Germany |
| Life Technologies United States |
| M |
| MBHB United States |
| mdc pharmaceuticals India |
| Medinoah China |
| Merck & Co.,Inc United States |
| Merck Serono China |
| Morrison & Foerster LLP China |
| MW Bridges China |
| N |
| New Stock Capital Sweden |
| Nucleus Network Limited Australia |
| O |
| Ocean University of China China |
| Otsuka Pharmaceutical Co., Ltd. Japan |
| Oxford BioMedica plc United Kingdom |
| P |
| PAA Laboratories GmbH Austria |
| Pfizer China |
| Pharma-GPS, LLC United States |
| Phytopharm plc United Kingdom |
| Ping Ge China |
| R |
| Ranbaxy Laboratories Limited India |
| Roche/Ventana United States |
| RXB Management Consulting China |
| S |
| Saint Nicholas Hospital Egypt |
| sanofipasteur China |
| SciClone Pharmaceuticals, Inc. United States |
| See-D4 Pty Ltd Australia |
| Shanghai Joyous Paradise Enterprise Management Co., Ltd. China |
| Sinova Pharmaceuticals China |
| Stainwei Biotech, Inc China |
| State Goverment of Victoria, Australia Australia |
| Summit plc United Kingdom |
| SuperGen, Inc. United States |
| SuppreMol GmbH Germany |
| Synergion Biotech, Inc United States |
| Sypharma Pty Ltd Australia |
| T |
| Teva Pharmaceutical Industries Israel |
| The Balloch Group China |
| Thomson Reuters China |
| Trident Clinical Research Australia |
| Trius Therapeutics United States |
| V |
| Valletta Health Netherlands |
| W |
| Wave 80 Biosciences United States |
| WilmerHale Germany |
| X |
| Xuyue (Beijing) Sci.&Tech. Co., Ltd. China |
